Ci Investments Inc. Zai Lab LTD Transaction History

Ci Investments Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$30.21 - $48.1 $1,993 - $3,174	66 Added 10.38%	702 $23,000
Q4 2022 Feb 10, 2023	BUY	$22.28 - $38.71 $11,763 - $20,438	528 Added 488.89%	636 $20,000
Q3 2021 Nov 12, 2021	BUY	$105.0 - $178.37 $1,890 - $3,210	18 Added 20.0%	108 $11,000
Q1 2021 May 13, 2021	BUY	$126.27 - $191.71 $3,788 - $5,751	30 Added 50.0%	90 $12,000
Q4 2020 Feb 09, 2021	BUY	$81.94 - $135.34 $2,458 - $4,060	30 Added 100.0%	60 $8,000
Q3 2020 Nov 09, 2020	BUY	$73.3 - $89.48 $2,199 - $2,684	30 New	30 $2,000

116

40.8M

63.1K

420K

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $3.02B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

Get notified when there are updates to the investment portfolio of Ci Investments Inc., based on Form 13F filings with the SEC.

Stay updated on Ci Investments Inc. with notifications on news.